Clinical Consultations and Investigations Before and After Discontinuation of Endocrine Therapy in Women with Primary Breast Cancer

This academic paper explores the reasons why women with hormone dependent primary breast cancer discontinue endocrine therapy, despite the fact it is recommended treatment for up to 5 years post treatment for cancer.

Skip to content